Spectral AI, Inc.

NASDAQ:MDAI

Medical - Devices

Healthcare
$1.57 +0.28%

+$0.01 today

Market cap
$50.53M
Beta
1.15
P/E (TTM)
-4.0
EPS (TTM)
-$0.45
52W Low $1.18High $3.21

Volume 0.07M

Average 1.00M

MDAI Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Spectral AI, Inc.NASDAQ: MDAI

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q1 FY2026 gross profit of $2.03M fell 36.0% year over year, ahead of the -44.7% change in trailing-twelve-month gross profit. Sequentially, it rose 32.4% from the prior quarter. Over 3 fiscal years it compounded at -6.3% a year.

Context

  • Gross profit amounted to 45.4% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -36.0% holds above the trailing-twelve-month pace of -44.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.03M+32.4% QoQ
Last fiscal yearDec 2025
$8.93M-32.8% YoY
LTMMar 2026
$7.47M-44.7% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-36.0%——
1 year-32.8%——
3-year CAGR-6.3%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
8.93M USD
Year-over-year change
-32.8%
4-year CAGR
+6.1%

Gross Profit vs competitors

How MDAI compares with its peers on the latest reported figures

  • MDAI's LTM Mar 2026 gross profit of $7.47M is the 5th highest of the 9 companies compared; the peer median is $4.87M.
  • Its year-over-year change of -44.7% is the 5th highest of 8, against a peer median of +6.2%.
  • Gross profit amounts to 44.7% of revenue for MDAI, versus a peer median of 87.2%.
MDAI Competitors Peer median
Gross Profit for MDAI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KPTIKaryopharm Therapeutics Inc.LTM Mar 2026$145.11M +6.2%-2.6%96.0%
TELATELA Bio, Inc.LTM Jun 2026$54.19M +6.9%+26.2%67.8%
ECORelectroCore, Inc.LTM Mar 2026$30.45M +35.0%+58.5%87.2%
SRTSSensus Healthcare, Inc.LTM Mar 2026$8.51M -61.6%-26.3%37.7%
MDAISpectral AI, Inc.LTM Mar 2026$7.47M -44.7%-6.3%44.7%
COEPCoeptis Therapeutics, Inc.LTM Mar 2026$1.23M +6860.8%—87.2%
TELOTelomir Pharmaceuticals, Inc. Common StockLTM Mar 2026$0 ———
EQEquillium, Inc.LTM Mar 2026-$79K -100.3%——
IPSCCentury Therapeutics, Inc.LTM Mar 2026-$29.86M -126.0%+164.4%—
Peer median (excluding MDAI) $4.87M+6.2%+26.2%87.2%

Competitors are the stored peer set for MDAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue15.24M25.37M18.06M29.58M19.65M
Cost of Revenue8.19M14.53M10.18M16.31M10.73M
Gross Profit7.05M10.84M7.88M13.27M8.93M
Gross Margin46.3%42.7%43.6%44.9%45.4%
Research & Development00029.58M19.65M
Selling, General & Admin11.23M13.48M20.86M19.86M17.53M
Operating Expenses11.23M13.48M20.86M19.86M17.53M
Depreciation & Amortization1K568K722K588K635K
EBITDA(4.09M)(2.24M)(20.12M)(11.49M)(5.42M)
EBITDA Margin-26.8%-8.8%-111.4%-38.8%-27.6%
Operating Income(4.18M)(2.65M)(12.98M)(6.58M)(8.6M)
Operating Margin-27.4%-10.4%-71.9%-22.3%-43.8%
Interest Income021K172K14K(886K)
Interest Expense0002.97M1.51M
Other Income / Expenses93K(159K)(7.86M)(8.46M)1.04M
Income Before Tax(4.09M)(2.81M)(20.84M)(15.04M)(7.56M)
Pre-Tax Margin-26.8%-11.1%-115.4%-50.9%-38.5%
Income Tax Expense(98K)106K11K271K11K
Net Income(3.99M)(2.91M)(20.85M)(15.32M)(7.57M)
Net Margin-26.2%-11.5%-115.5%-51.8%-38.5%
EPS (Basic)(0.33)(0.16)(1.48)(0.85)(0.29)
EPS (Diluted)(0.33)(0.16)(1.48)(0.85)(0.29)
Weighted Avg Shares17.88M17.88M14.09M17.93M26.52M
Weighted Avg Shares (Diluted)17.88M17.88M14.09M17.93M26.52M

Spectral AI, Inc.

NASDAQ:MDAI

Intrinsic Alpha fair value

Locked

Current Price

$1.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.